Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

NCT05765344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Healthy

Interventions

DRUG: Bulevirtide
DRUG: Bulevirtide

Sponsor

Gilead Sciences